oseltamivir has been researched along with Cough in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 9 (42.86) | 24.3611 |
| 2020's | 9 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, YL; Hu, CC; Li, WF; Yuan, B | 1 |
| Guo, YH; Li, B; Li, ZY; Liu, QQ; Yan, YM; Yang, XJ; Zhao, CX; Zhao, GZ | 1 |
| Akyollu, B; Arpali, E; Kocak, B; Tekin, S; Turkmen, A; Yelken, B | 1 |
| Çapar, G; Köse, M; Medetalibeyoğlu, A; Şenkal, N; Tükek, T | 1 |
| Gao, J; Li, D; Xia, H; Xiu, M | 1 |
| Firouzabadi, FD; Firouzabadi, MD; Ghalehbaghi, B; Goudarzi, S; Jahandideh, H; Roomiani, M | 1 |
| Altunok, ES; Cengel, F; Ekin, EE; Gurkan, O; Yilmaz, A | 1 |
| Aghavali, S; Babadi, M; Daraie, P; Emamikhah, M; Jalili, M; Mehrabani, M; Mohaghegh, F; Pouranian, M; Rohani, M; Zaribafian, M | 1 |
| Aalipour, MA; Darazam, IA; Ghorbani, F; Pakdaman, H; Ramezani, M; Sagharichi, M; Simani, L | 1 |
| Bahirwani, J; Gonakoti, S; Maddala, RNM; Vidyasagar, S | 1 |
| Bromley, C; Reynard, C | 1 |
| Blumentals, WA; Miller, MK; Rath, BA; Starzyk, K; Tetiurka, B; Wollenhaupt, M | 1 |
| Chida, J; Ito, C; Iwase, K; Kido, H; Mizuno, D; Sawabuchi, T; Suzuki, S; Talukder, SR; Togari, H; Watanabe, I | 1 |
| Bender, M; Bernheisel, C | 1 |
| Calitri, C; Cuozzo, M; Gabiano, C; Garazzino, S; Pinon, M; Scolfaro, C; Tovo, PA; Zoppo, M | 1 |
| Dembiński, Ł; Jackowska, T; Marczyńska, M; Radzikowski, A; Smalisz-Skrzypczyk, K; Talarek, E | 1 |
| Basson, E; Boibieux, A; Haÿs, S; Leick-Courtois, C; Lina, B; Perpoint, T; Picaud, JC; Valette, M | 1 |
| Blanchon, T; Carrat, F; Duval, X; Flahault, A; Leport, C; Mentré, F; Mosnier, A; Tibi, A; Tubach, F; Van der Werf, S | 1 |
| Monto, AS; Ohmit, SE | 1 |
| Dutkowski, R; Hayden, FG; Ipe, D; Mills, RG; Reisinger, KS; Ward, P; Whitley, RJ; Young, N | 1 |
5 review(s) available for oseltamivir and Cough
| Article | Year |
|---|---|
[Overview of Meta-analysis of Lianhua Qingwen preparations in treatment of viral diseases].
Topics: Cough; COVID-19 Drug Treatment; Drugs, Chinese Herbal; Fatigue; Fever; Humans; Influenza, Human; Meta-Analysis as Topic; Nonprescription Drugs; Nucleic Acids; Oseltamivir; Ribavirin | 2022 |
[Systematic review and Meta-analysis of Lianhua Qingwen preparations combined with Oseltamivir in treatment of influenza].
Topics: Cough; Drugs, Chinese Herbal; Humans; Influenza, Human; Myalgia; Nucleic Acids; Oseltamivir; Pharyngitis; Rhinorrhea | 2022 |
Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
Topics: Adult; Anticonvulsants; Ataxia; Azithromycin; Clonazepam; Cough; COVID-19; COVID-19 Drug Treatment; Dyspnea; Female; Fever; Humans; Hydroxychloroquine; Levetiracetam; Male; Middle Aged; Myalgia; Opsoclonus-Myoclonus Syndrome; Oseltamivir; SARS-CoV-2; Valproic Acid | 2021 |
EMERGING PATHOGENS: INFLUENZA - H7N9.
Topics: Animals; Antiviral Agents; Birds; Communicable Diseases, Emerging; Cough; Fever; Humans; Influenza A Virus, H7N9 Subtype; Influenza in Birds; Influenza Vaccines; Influenza, Human; Oseltamivir; Poultry; Radiography, Thoracic; Respiratory Distress Syndrome; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction | 2017 |
BET 1: Oseltamivir use for quicker alleviation of symptoms, fewer hospital admissions and lower mortality in adult patients with influenza B.
Topics: Antiviral Agents; Cough; Emergency Service, Hospital; Evidence-Based Emergency Medicine; Fatigue; Humans; Influenza B virus; Influenza, Human; Male; Middle Aged; Oseltamivir | 2019 |
2 trial(s) available for oseltamivir and Cough
| Article | Year |
|---|---|
Effect of oseltamivir, zanamivir or oseltamivir-zanamivir combination treatments on transmission of influenza in households.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Cough; Drug Therapy, Combination; Enzyme Inhibitors; Family Characteristics; Female; Fever; Follow-Up Studies; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Male; Middle Aged; Multivariate Analysis; Neuraminidase; Oseltamivir; Time Factors; Young Adult; Zanamivir | 2012 |
Oral oseltamivir treatment of influenza in children.
Topics: Acetamides; Administration, Oral; Antiviral Agents; Child; Child, Preschool; Cough; Double-Blind Method; Female; Humans; Infant; Influenza, Human; Male; Oseltamivir; Safety; Time Factors; Treatment Outcome | 2001 |
14 other study(ies) available for oseltamivir and Cough
| Article | Year |
|---|---|
Case report: A kidney transplant patient with mild COVID-19.
Topics: Adult; Antiviral Agents; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; COVID-19 Drug Treatment; Disease Management; Female; Fever; Glucocorticoids; Graft Rejection; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lupus Nephritis; Oseltamivir; Pandemics; Pneumonia, Viral; Prednisone; SARS-CoV-2; Severity of Illness Index; Tacrolimus | 2020 |
Characteristics of the initial patients hospitalized for COVID-19: a single-center report
Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Antihypertensive Agents; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; Female; Fever; Health Personnel; Humans; Hydroxychloroquine; Hypertension; Intensive Care Units; Lung; Male; Middle Aged; Myalgia; Oseltamivir; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Smoking; Tomography, X-Ray Computed; Travel; Turkey; Young Adult | 2020 |
Community-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus in a Chinese adult: A case report.
Topics: Aged; Anti-Bacterial Agents; Cough; Healthcare-Associated Pneumonia; Humans; Hypokinesia; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Mezlocillin; Oseltamivir; Shock, Septic; Staphylococcal Infections | 2020 |
Have the symptoms of patients with COVID-19 changed over time during hospitalization?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Coronavirus Infections; Cough; COVID-19; Diarrhea; Dyspnea; Female; Fever; Hospitalization; Humans; Hydroxychloroquine; Iran; Length of Stay; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Symptom Assessment; Young Adult | 2020 |
COVID-19 Pulmonary Infection with Pneumothorax in a Young Patient.
Topics: Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus; Coronavirus Infections; Cough; COVID-19; Enoxaparin; Female; Fever; Humans; Hydroxychloroquine; Lung; Male; Oseltamivir; Pandemics; Pneumonia, Viral; Pneumothorax; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2020 |
Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.
Topics: Adult; Aged; Antiviral Agents; Cough; COVID-19; COVID-19 Drug Treatment; Dementia; Drug Combinations; Dyspnea; Fatigue Syndrome, Chronic; Female; Fever; Humans; Hydroxychloroquine; Lopinavir; Male; Middle Aged; Oseltamivir; Research Design; Ritonavir; SARS-CoV-2; Severity of Illness Index; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Survivors | 2021 |
A case of H3N2 complicated by acute kidney injury secondary to rhabdomyolysis.
Topics: Acute Kidney Injury; Aged, 80 and over; Antiviral Agents; Bronchodilator Agents; Cough; Fever; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Male; Methylprednisolone; Myalgia; Oseltamivir; Respiratory Distress Syndrome; Rhabdomyolysis; Treatment Outcome | 2018 |
A prospective observational study of oseltamivir safety and tolerability in infants and young children ≤24 months.
Topics: Antiviral Agents; Cough; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Influenza, Human; Male; Oseltamivir; Prospective Studies; Vomiting | 2015 |
Boost of mucosal secretory immunoglobulin A response by clarithromycin in paediatric influenza.
Topics: Adolescent; Anti-Bacterial Agents; Antiviral Agents; Child; Child, Preschool; Clarithromycin; Cough; Drug Therapy, Combination; Humans; Immunoglobulin A; Infant; Influenza A virus; Influenza, Human; Nasal Mucosa; Oseltamivir; Prevalence; Retrospective Studies; RNA, Viral; Treatment Outcome | 2009 |
Fever, cough, and hypoxia in a pregnant woman.
Topics: Adult; Antiviral Agents; Cough; Female; Fever; Humans; Hypoxia; Influenza A Virus, H1N1 Subtype; Oseltamivir; Oxygen Inhalation Therapy; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Respiratory Distress Syndrome; Vomiting | 2010 |
Clinical features of hospitalised children with 2009 H1N1 influenza virus infection.
Topics: Adolescent; Antiviral Agents; Child; Child, Hospitalized; Child, Preschool; Cough; Female; Fever; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Italy; Lung Diseases; Male; Medical Records; Nervous System Diseases; Oseltamivir; Treatment Outcome | 2010 |
[Clinical course of influenza A(H1N1)v in children treated in Warsaw in season 2009/2010].
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Communicable Diseases, Emerging; Comorbidity; Cough; Female; Fever; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Pneumonia; Poland; Retrospective Studies; Seasons; Treatment Outcome; Urban Population | 2010 |
[Influenza A H1N1 in neonatal intensive care unit: analysis and lessons].
Topics: Antiviral Agents; Apnea; Cough; Disease Outbreaks; Female; Follow-Up Studies; France; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units, Neonatal; Male; Oseltamivir; Polymerase Chain Reaction; Respiration, Artificial; Treatment Outcome; Twins, Monozygotic | 2011 |
Symptomatic predictors of influenza virus positivity in children during the influenza season.
Topics: Acetamides; Aging; Antiviral Agents; Child; Child, Preschool; Cough; Fever; Guanidines; Headache; Humans; Infant; Influenza, Human; Logistic Models; Muscular Diseases; Odds Ratio; Oseltamivir; Pyrans; Risk Factors; Seasons; Sialic Acids; Zanamivir | 2006 |